Affymetrix Names Kevin King President of Life Sciences Business
Affymetrix Inc. announced that it has appointed Kevin M. King to president of Life Sciences business and executive vice president, reporting to Stephen P.A. Fodor, Ph.D., chairman and CEO. King previously served as president and CEO of Thomson Healthcare, the $500 million healthcare and pharmaceutical information services division of Thomson Corporation.
King will be responsible for managing Affymetrix' growing life sciences business. He brings more than 25 years of industry experience to Affymetrix. At Thomson Healthcare, King was responsible for developing and implementing the growth strategy that led to its industry leading position within the $7 billion healthcare decision support market. King has also held senior executive positions at General Electric Healthcare, including vice president and general manager, Global Clinical Systems. In that position, he grew the business to more than $900 million in revenue through the global sales distribution expansion, introduction of new technologies and strategic acquisitions. In addition, King brings more than 14 years of experience at Hewlett-Packard, where his many accomplishments included the creation of a web-enabled systems strategy to help speed up the drug discovery process and reduce the time to complete clinical trials.
Other news from the department people
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.
